Name | Value |
---|---|
Revenues | 0.0K |
Cost of Revenue | 0.4K |
Gross Profit | -0.4K |
Operating Expense | 1,965.3K |
Operating I/L | -1,965.7K |
Other Income/Expense | 61.9K |
Interest Income | 65.2K |
Pretax | -1,903.8K |
Income Tax Expense | -0.0K |
Net Income/Loss | -1,903.8K |
BullFrog AI Holdings, Inc. operates as a digital biopharmaceutical company specializing in AI/ML-driven analysis of medical and healthcare data. Its flagship product, bfLEAP, is an AI/ML platform for preclinical and clinical data analysis. The company generates revenue through licensing agreements with research institutions for the use of innovative treatments targeting human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis.